Anzeige
Erschienen in:
27.01.2017 | Head and Neck Oncology
Lymph Node Ratio Predicts Recurrence and Survival for Patients with Resectable Stage 4 Hypopharyngeal Cancer
Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2017
Einloggen, um Zugang zu erhaltenAbstract
Background
This study aimed to investigate the clinicopathologic prognostic predictors of stage 4 hypopharyngeal cancer and to extend the traditional tumor-node-metastasis classification system to advance its predictive ability.
Methods
The study enrolled 120 patients with pathologically stage 4 hypopharyngeal cancer treated with pharyngolaryngectomy and neck dissection between 2001 and 2007.
Results
The study showed a 5-year overall survival (OS) of 44.6%, a disease-specific survival (DSS) of 51.6%, and a disease-free survival (DFS) of 48% for all the patients. In the multivariate analysis, a lymph node (LN) ratio of 0.113 or higher was a significant poor prognostic factor for OS (hazard ratio [HR] 1.89; 95% confidence interval [CI] 1.17–3.05; p = 0.009), DSS (HR 2.17; 95% CI 1.29–3.64; p = 0.003), and DFS (HR, 2.24; 95% CI 1.12–4.52; p = 0.024) in stage 4 hypopharyngeal cancer. In addition, pretreatment neutrophil–lymphocyte ratio, lymphovascular invasion, and margin status also were predictors of survival outcomes. Furthermore, the study found that disease recurrence differed significantly between the patients with a LN ratio of 0.113 or higher (68.2%) and those with a LN ratio lower than 0.113 (39.5%) (p = 0.002).
Conclusions
A LN ratio of 0.113 or higher is a strong predictor of disease recurrence and survival for patients with stage 4 hypopharyngeal cancer.